ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Hydromorphone Mundipharma Retard 4 mg, Retardkapseln - 30
70347001 CMMundipharma Medical Company, Hamilton, Bermuda, Basel Branch
Hydromorphone Mundipharma Retard 4 mg, Retardkapseln18.07.2025
  18.07.2025
Hydromorphone (N02AA03) 
WHO-DDD 
30
01.01.30. 
A+  
No 
  
PR  
k.A.PR
  
7680703470015Synthetika
  
Composition
hydromorphoni hydrochloridum 4 mg corresp. hydromorphonum 3.55 mg, cellulosum microcristallinum, hypromellosum, ethylcellulosum, silica colloidalis anhydrica, dibutylis sebacas, Kapselhülle: gelatina, natrii laurilsulfas corresp. natrium 0.006 mg, E 127, E 132, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro capsula.
Packungsbestandteile
Retard-Kapseln
 
Active AgentDose
Hydromorphon Hydrochlorid4 mg correspond Hydromorphon 3.55 mg
 
Inactive agents additional_information
(Nigrum)  
Cellulosum Microcristallinum  
Dibutylis Sebacas  
E 127 color.
E 132 color.
E 171 color.
E 172 color.
Ethylcellulosum  
Gelatina Kapselhülle
Hypromellosum  
Lacca Drucktinte
Natrii Laurilsulfas  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
Source
Data was imported : 07.08.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home